Additionally, beyond lysosomal dysfunction, impaired expression of Endophilin A2 (Endo II) in HER2-positive (HER2+) breast cancer models reduced HER2 internalization and diminished the response to T-DM1 (57). The gene discussed is ERBB2; the disease is breast carcinoma.